Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07053176Phase 4Enrolling By Invitation

Impact of Local Lidocaine Paravertebral Cervical Injection on Cervicogenic Dizziness Symptoms

Role: lead

NCT04529161Not ApplicableCompleted

Olfactory and Taste Changes During Fasting Mimicking Diet (FMD)

Role: lead

NCT05174104Not ApplicableCompleted

Metabolic and Chronobiological Changes in Vestibular Rehabilitation

Role: lead

NCT04353908Not ApplicableCompleted

Collagen Treatment in Facial Nerve Palsy

Role: lead

NCT04347148Not ApplicableCompleted

Postural and Clinical Outcomes of SNAGs Treatment in Cervicogenic Dizziness Patients: a Randomised Controlled Trial

Role: lead

NCT03553264Not ApplicableUnknown

Three-dimensional Virtual Reality Procedures in Vestibular Rehabilitation

Role: lead

All 6 trials loaded